BRIEF published on 08/13/2025 at 07:05, 1 year 1 month ago Evotec SE Reports H1 2025 Results Highlighting Strategic Progress Financial Performance Evotec SE Strategic Growth Biologics Development H1 2025 Results
PRESS RELEASE published on 08/13/2025 at 07:00, 1 year 1 month ago Evotec SE reports H1 2025 results: Strong progress on strategy execution Evotec SE reports strong progress on strategy execution with H1 2025 results, showcasing sustainable profitable growth and key collaborations with BMS and Sandoz Evotec SE Growth Collaborations Strategy Execution H1 2025 Results
BRIEF published on 08/06/2025 at 09:57, 1 year 1 month ago Evotec SE to Release First Half-Year Results 2025 Conference Call Drug Discovery Life Sciences Evotec SE Half-year Results
PRESS RELEASE published on 08/06/2025 at 09:52, 1 year 1 month ago Evotec SE to announce first half-year results 2025 on 13 August 2025 Evotec SE to announce first half-year results for 2025 on 13 August 2025 with a conference call to discuss performance. Company focuses on drug discovery and development Conference Call Drug Discovery Evotec SE Half-year Results AI-driven Innovation
BRIEF published on 07/30/2025 at 07:21, 1 year 1 month ago Evotec and Sandoz Advance Partnership with Potential Toulouse Site Sale Strategic Partnership Evotec SE Biologics Manufacturing Sandoz AG Asset-Lighter Model
BRIEF published on 07/30/2025 at 07:19, 1 year 1 month ago Evotec SE and Sandoz AG to Potentially Sell Just – Evotec Biologics Toulouse Site Evotec SE Transaction Terms Sandoz AG Biologics Sale Toulouse Site
PRESS RELEASE published on 07/30/2025 at 07:16, 1 year 1 month ago Evotec and Sandoz evolve their strategic partnership and agree on potential sale of Just – Evotec Biologics Toulouse site Evotec and Sandoz agree on potential sale of Just – Evotec Biologics Toulouse site in strategic partnership evolution Strategic Partnership Sale Evotec Sandoz Biologics
PRESS RELEASE published on 07/30/2025 at 07:14, 1 year 1 month ago EQS-Adhoc: Evotec SE and Sandoz AG planning potential sale of Just – Evotec Biologics Toulouse site Evotec SE and Sandoz AG plan potential sale of Just - Evotec Biologics Toulouse site for $300m in cash with additional technology related consideration. Evotec to retain economic upside Evotec SE Sale Just - Evotec Biologics Toulouse Sandoz AG
BRIEF published on 07/21/2025 at 11:45, 1 year 1 month ago Evotec Adjusts Revenue Guidance for 2025 Profit Guidance Cost Optimization Evotec Revenue Guidance High-margin Technology 2028 Outlook
PRESS RELEASE published on 07/21/2025 at 11:40, 1 year 1 month ago Evotec adjusts revenue guidance and confirms profit guidance anticipating a more profitable revenue mix Evotec SE adjusts revenue guidance for fiscal year 2025, sticking to profit guidance with a focus on high-margin technology license revenues and cost optimization Evotec SE Profit Guidance Cost Optimization Revenue Guidance High-margin Technology
Published on 09/16/2026 at 16:55, 5 hours 34 minutes ago CORRECTION FROM SOURCE: SLAM Reports 1.60% Copper Equivalent Over 14.45 Meters in Hole GW26-33; Trenching Gold-Antimony Targets on Moose Lake Project
Published on 09/16/2026 at 15:00, 7 hours 29 minutes ago 2026 Canada's Top 40 Under 40(R) Honourees Announced
Published on 09/16/2026 at 14:00, 8 hours 29 minutes ago Ameriwest Awaits Bornite Core Assay Results and Provides Q3 2026 Corporate Update
Published on 09/16/2026 at 13:30, 8 hours 59 minutes ago Sterling Extends Core MEPS Copper Zone to 700m; Intersects 200m of 0.53% CuEq Including 102m of 0.81% CuEq
Published on 09/16/2026 at 21:15, 1 hour 14 minutes ago Gastech 2026 in Bangkok Converts Global Energy Ambition into Billions of Dollars in Deals
Published on 09/16/2026 at 20:27, 2 hours 1 minute ago EQS-Adhoc: REPLOID Group AG resolves to issue convertible notes in an aggregate principal amount of up to EUR 30 million
Published on 09/16/2026 at 19:05, 3 hours 24 minutes ago EcoFlow to showcase its open home energy ecosystem at Solar & Storage Live Zurich 2026
Published on 09/16/2026 at 18:22, 4 hours 7 minutes ago EQS-Adhoc: elumeo SE resolves on a capital increase against cash contributions, ex-cluding pre-emptive rights, and a move to the Scale segment
Published on 09/16/2026 at 18:11, 4 hours 17 minutes ago EQS-Adhoc: Berentzen-Gruppe Aktiengesellschaft confirms rumours regarding negotiations on a voluntary takeover offer by SAZERAC COMPANY, INC.
Published on 09/16/2026 at 17:45, 4 hours 44 minutes ago Report on share repurchases from 9 to 15 September 2026
Published on 09/16/2026 at 07:00, 15 hours 29 minutes ago bioMérieux Receives IVDR Class D CE Marking for BIOFIRE® Respiratory 2.1 plus Panel and BIOFIRE® FILMARRAY® Pneumonia plus Panel, the first syndromic tests including MERS-CoV to achieve this certification
Published on 09/15/2026 at 18:00, 1 day 4 hours ago Report on the Combined General Meeting of the 10th of September 2026
